BeyondSpring Inc. (BYSI) vs MIRA Pharmaceuticals, Inc. (MIRA)

A side-by-side comparison of BeyondSpring Inc. and MIRA Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
BeyondSpring Inc. logo
BYSI
BeyondSpring Inc.
$30M
$0.72HealthcareDelayed quote: Oct 6, 2026, 3:31 PM EDT
MIRA Pharmaceuticals, Inc. logo
MIRA
MIRA Pharmaceuticals, Inc.
$30M
$0.72HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT

Total return — BYSI vs MIRA

growth of $100 · dividends reinvested · last 3y
BYSI -22.2% (-8.0%/yr)MIRA -88.5% (-51.4%/yr)BYSI compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $100202420252026$78$11
BYSI MIRA

BYSI vs MIRA: by the numbers

  • •MIRA is the larger company ($30M vs $30M market cap).

Metrics side by side

Valuation

MetricBYSIMIRA
P/B ratioN/A3.68

Profitability

MetricBYSIMIRA
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROEN/A-116.14%
ROICN/A-115.18%

Growth (annualized)

MetricBYSIMIRA
Total return CAGR (5Y)-44.30%N/A

Go deeper

Full BYSI analysisFull MIRA analysisInteractive comparison tool

Dig into the metrics

BeyondSpring ROEMIRA Pharmaceuticals ROEBeyondSpring operating marginMIRA Pharmaceuticals operating marginBeyondSpring revenue growthMIRA Pharmaceuticals revenue growthBeyondSpring free cash flowMIRA Pharmaceuticals free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.